Why Is Nano-Cap Cancer-Focused Xilio Therapeutics Stock Trading Over 100% On Wednesday?
AbbVie Inc (NYSE:ABBV) and Xilio Therapeutics, Inc. (NASDAQ:XLO) announced a collaboration and option-to-license agreement to ...
조선일보13 天
Korean researchers develop Trojan horse method to produce antibodies in tumors
Korean researchers develop Trojan horse method to produce antibodies in tumors Innovative nanoparticle platform creates tumor ...
Nature10 个月
Therapeutic antibodies: past, present and future
Over the past 10 years, the market for monoclonal antibodies has grown exponentially. This focus issue brings together articles on the basic biology of antibodies and their therapeutic use ...
Nanomachines loaded with wine ingredients overcome gene therapy challenges
Researchers have demonstrated, for the first time in the world using mice, the ability to overcome significant challenges in ...
来自MSN1 个月
A tiny anticancer weapon: Nano-sized particles trigger tumor cell self-destruction
The new approach, using engineered sEVs to target DR5, outperformed DR5-targeting antibodies ... vesicles to target DR5 because these nano-sized capsules—about a million times smaller than ...